Last reviewed · How we verify
NCT04193163: ESOP2
Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device
trial testing Hip prosthesis - ESOP 2 cementless femoral stem in Hip Disease in 10 participants. Terminated before completion.
1 September 2022
Quick facts
| Lead sponsor | FH ORTHO |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 1 December 2019 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 7 locations across France |
Drugs / interventions tested
- Hip prosthesis - ESOP 2 cementless femoral stem
Conditions studied
- Hip Disease — all drugs for Hip Disease →
- Hip Fractures — all drugs for Hip Fractures →
Sponsor
FH ORTHO
Who can join
18 and older, any sex, with Hip Disease or Hip Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a post-market clinical follow-up conducted in order to collect long-term data on security and performance of the ESOP 2 stem, which is intended to be implanted in case of total hip replacement, when used in real life conditions according to the instructions for use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04193163
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Disease
Currently open trials in the same condition.
- NCT07023094 — PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery · Phase 4 · recruiting
- NCT07147530 — Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joi · Phase 4 · recruiting
- NCT06153940 — Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up · recruiting
- NCT04028687 — MDR - PMCF Study for Taperloc Complete Stems · recruiting
Other FH ORTHO trials
Trials by the same sponsor.
- NCT06511856 — FH ORTHO Shoulder Observatory · recruiting
- NCT06234358 — A Clinical Study Carried Out in Patients Operated With Calcanail® · completed
- NCT04944576 — Observational Study to Evaluate Safety and Performance of the Total Ankle Prosthesis, EasyMove® · active not recruiting
- NCT04578951 — Measurement of the Quality of Life in Patients Operated With a Total Knee Prosthesis (TKA) From the FHK® Range. · terminated
- NCT04221581 — Study Conducted on Patients Operated With a FHK ASYMETRIQUE to Confirm Security and Performance of the Device · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04193163 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FH ORTHO
- Last refreshed: 2 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04193163.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing